Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.
Earnings for Nexstim Plc (NXTMH.HE)
Earnings in 2023 (TTM): $-1,382,773
According to Nexstim Plc's latest financial reports the company's current earnings (TTM) are $-1,382,773. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Nexstim Plc
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-1,382,773 | $-1,387,826 |
| 2022 | $1.37 M | $1.37 M |
| 2021 | $-766,567 | $-869,910 |
| 2020 | $-4,303,660 | $-4,308,863 |
| 2019 | $-7,084,795 | $-7,090,778 |
| 2018 | $-6,432,108 | $-6,433,913 |
| 2017 | $-7,657,905 | $-7,660,837 |
| 2016 | $-7,036,174 | $-7,038,577 |
| 2015 | $-10,271,978 | $-10,273,425 |
| 2014 | $-10,919,935 | $-10,919,935 |
| 2013 | $-4,720,054 | $-4,720,054 |
| 2012 | $-2,821,578 | $-2,821,578 |